Summary
Neurodegenerative diseases have been linked to inflammation, but whether altered immunomodulation plays a causative role in neurodegeneration is not clear. We show that lack of cytokine interferon-β (IFN-β) signaling causes spontaneous neurodegeneration in the absence of neurodegenerative disease-causing mutant proteins. Mice lacking Ifnb function exhibited motor and cognitive learning impairments with accompanying α-synuclein-containing Lewy bodies in the brain, as well as a reduction in dopaminergic neurons and defective dopamine signaling in the nigrostriatal region. Lack of IFN-β signaling caused defects in neuronal autophagy prior to α-synucleinopathy, which was associated with accumulation of senescent mitochondria. Recombinant IFN-β promoted neurite growth and branching, autophagy flux, and α-synuclein degradation in neurons. In addition, lentiviral IFN-β overexpression prevented dopaminergic neuron loss in a familial Parkinson’s disease model. These results indicate a protective role for IFN-β in neuronal homeostasis and validate Ifnb mutant mice as a model for sporadic Lewy body and Parkinson’s disease dementia.
Graphical Abstract
Highlights
-
•
Lack of neuronal IFN-β-IFNAR signaling causes brain Lewy body accumulation
-
•
IFN-β deficiency causes late-stage autophagy block and thereby α-synuclein aggregation
-
•
IFN-β promotes neuronal autophagy and α-synuclein clearance
-
•
Ifnb gene therapy prevents dopaminergic neuron loss in a familial PD model
Lack of the immunomodulatory cytokine interferon-β (IFN-β) causes spontaneous neurodegeneration resembling sporadic Lewy body and Parkinson’s disease dementia due to defects in neuronal autophagy.
Introduction
Neurodegenerative diseases have disrupted neuronal homeostasis and their pathologies often overlap. Protein aggregates containing α-synuclein (α-syn), which eventually forms larger Lewy bodies (LBs), are seen in Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy, and in some forms of Alzheimer’s disease (AD), all neurodegenerative diseases associated with aging (Arima et al., 1999; Francis, 2009; Lippa et al., 1998). Often, the protein aggregates contain hyperphosphorylated tau and ubiquitin (Jellinger and Attems, 2008).
Neurodegenerative events in these diseases are linked to inflammation (Mrak and Griffin, 2007; Tansey et al., 2008), but, despite this link, defects in genes regulating inflammation do not have an established causative role in neurodegeneration. We report that deletion of Ifnb, which encodes interferon-β (IFN-β), is sufficient to cause a cascade of neurodegenerative events. IFN-β belongs to the type I interferon family of cytokines and binding to its receptor, interferon-α/β receptor (IFNAR), results in immunoregulation including anti-viral and anti-inflammatory effects (Prinz et al., 2008; Teige et al., 2003, 2006) and benefits for multiple sclerosis patients (Liu et al., 2014; Yong et al., 1998). However, the role of IFN-β in classic neurodegenerative diseases is unknown. We report that Ifnb–/– mice developed spontaneous pathologies mimicking major aspects of human neurodegeneration such as PD and DLB. Ifnb–/– mice had age-associated motor learning defects, neuromuscular deficiencies, and cognitive impairment. Ifnb–/– pathology was associated with LBs resulting from defective neuronal autophagy. Autophagy, a pathway that degrades long-lived proteins, organelles, lipids, and protein aggregates, is essential for neuronal homeostasis (Harris and Rubinsztein, 2012), and deleting neural autophagy-regulating genes leads to neurodegeneration (Hara et al., 2006; Komatsu et al., 2006).
Our findings indicate a central role for IFN-β in neuronal homeostasis as a regulator of autophagy-mediated protein degradation and accentuates Ifnb–/– mice as a model for neurodegenerative diseases with α-synucleinopathy and dementia such as PD and DLB.
Results
Ifnb–/– Mice Exhibit Behavioral and Cognitive Impairments and Neurodegeneration
We examined the effect of Ifnb gene deletion on motor coordination, learning, and grip strength. Ifnb–/– mice were significantly impaired in motor coordination and learning from 3 months compared to age-, sex-, and weight-matched wild-type (WT) Ifnb+/+ littermates and in latency-to-fall time in a wire-suspension test (Figures 1A and 1B). We saw no differences in 1.5-month-old mice, suggesting that impaired motor coordination, balance, and grip strength were associated with age. During repeated motor-learning trials, retention time improved significantly in older Ifnb+/+ mice compared to Ifnb–/– mice from age 3 months (Figure S1A), showing that reduced motor-learning in Ifnb–/– mice was associated with aging.
We assessed somatosensory function with nociception cold- and heat-induced tail-flick tests. Latency to tail flick was significantly shorter in Ifnb–/– than Ifnb+/+ mice (Figures 1C and 1D), indicating hyperalgesia and defective nociception toward temperature-induced pain.
Forced swimming tests found no differences between Ifnb–/– and Ifnb+/+ mice in swimming pattern, climbing effort, or immobility (Figure S1), so Ifnb–/– mice were not defective in locomotor activity in water in contrast to land. In water maze tests, Ifnb–/– mice had significant spatial- and memory-learning deficits that increased with age. During second tests, 6- and 12-month-old, Ifnb–/– mice had significantly fewer platform position crossings compared to Ifnb+/+ mice, indicating impaired reference memory (Figures 1E and 1F). Ifnb+/+ mice improved between the first and second tests at all ages except 12 months; Ifnb–/– mice did not improve, indicating impaired spatial learning. This was seen at all ages in Ifnb–/– mice measured by escape latency time in the second learning block (Figures S1B and S1C). Thus, although Ifnb–/– mice began with no major behavioral and cognitive defects, they developed age-dependent deficits with increased penetrance (Table S1).
IFN-β Is Essential for Neuronal Survival, Neurite Outgrowth, and Branching
We investigated whether Ifnb–/– behavioral deficits were associated with neurodegeneration. Apoptotic cells were detected in 1.5-month-old Ifnb–/– granular layers of olfactory bulbs (Figure S1E), the granular dentate gyrus of hippocampus and the subventricular zone (Figure 1G), and the striatum (STR) caudate putamen including the ependymal cell layer in 12-month-old Ifnb–/– mice (Figure S1F), but not detected in Ifnb+/+ sagittal brain sections at similar ages. Apoptotic neurons increased in cultured Ifnb–/– primary cerebellar granular neurons (CGNs) and was reversed by recombinant (r)IFN-β (Figures S1G and S1H). Neurons were significantly reduced in the hippocampal CA1 region in 3- to 6-month-old Ifnb–/– mice and decreased in Purkinje cells of cerebellum. Glial cell counts were unchanged (Figures 1H and 1I).
Supporting in vivo deficits in neuronal circuits, Ifnb–/– mice had reduced neurite network formation in the cerebellum, frontal cortex, and hippocampus granular cell layer (Figure 1J). This was confirmed in cultured Ifnb–/– primary cortical neurons (CNs) that had reduced neurite length per cell, mean length, and branch length per cell after 4 days, with restoration by rIFN-β (Figures 1K and 1L). A similar trend was seen after 21 days of culture (Figure 1K). Cultured primary Ifnb–/– CGNs mimicked the findings of CNs (Figures S1I and S1J). Thus, behavioral defects in old Ifnb–/– mice were associated with neuron death and reduced neurite circuits.
Ifnb–/– Neuron Gene Profiling Reveals Neurodegenerative Paths
We identified neuron-specific signaling and disease pathways caused by IFN-β deficiency with expression microarrays on highly pure (>98%) primary CGNs from Ifnb–/– and Ifnb+/+ mice plus or minus rIFN-β. Ifnb–/– neurons had 323 upregulated and 233 downregulated genes (Figures 2A, 2B, and S2A). rIFN-β treatment had differential effects on Ifnb+/+ versus Ifnb–/– CGNs with approximately equal numbers of downregulated and upregulated genes, but with relatively few overlaps (Figures 2C–2F). Multiple genes in the Ifnb–/– data set annotated as neuronal degeneration and the top ten pathways included cell death and neurological disorders. Genes in neurite formation and branching suggested compromised neurogenesis pathways in Ifnb–/– neurons, supporting the in vitro and in vivo phenotypes (Figures 2G and 2H). To investigate whether Ifnb and signaling via IFNAR affected neurogenesis in vivo, 3-month-old Ifnb–/– and IFNAR knockout (KO) mice (Ifnar–/–) and WT littermates were injected with bromodeoxyuridine (BrdU). Lack of Ifnb or receptor was associated with reduced neurogenesis in the hippocampus; dentate gyrus (Figure 2I), supporting the microarray data. IFN-β might directly affect prosurvival mechanisms as neurotrophin was among the top hits in gene set enrichment analysis (GSEA) (Table S2) and mRNA for the corticogenesis-regulating transcription factor Tox (Artegiani et al., 2015) was reduced in Ifnb–/– neurons (Figure S2A). Increased apoptosis and reduced neurogenesis might contribute to impaired cognition and reduced hippocampal neuron numbers. GSEA of Ifnb+/+ and Ifnb–/– showed enrichment of genes associated with Huntington’s disease (HD), PD, AD, and prion diseases, and rIFN-β caused the Ifnb–/– profile to resemble WT (Figure 2J), supporting that common pathways link neurodegenerative diseases (Shulman and De Jager, 2009).
We compared the Ifnb–/– neuronal gene profile with PD and HD mouse models (Fossale et al., 2011). Three sets of differentially expressed genes were generated: differentially expressed in our data (p < 0.001), in our data and the HD model (p < 0.01), or our data and the PD model (p < 0.01) (Figures S2A–S2C; Data S1). Clustered genes in Ifnb–/– neurons and the HD model were both similarly and oppositely regulated. In contrast, most clustered genes in Ifnb–/– neurons and the PD model were regulated similarly, thus indicating a higher gene signature resemblance with PD than HD (Figures S2B and S2C).
Lack of Ifnb Causes Defects in the Nigrostriatal Dopaminergic Pathway
Based on the possible PD-related defect in Ifnb–/– neurons, we investigated nigrostriatal region integrity. Tyrosine hydroxylase (TH)+ fiber density and TH+ (dopamine-producing) neurons were significantly reduced in the STR and substantia nigra (SN) in Ifnb–/– mice versus WT (Figures 2K and 2L). NeuN+ and NeuN+TH+ cells were reduced in the ventral midbrain, which was correlated with reduced TH protein in basal ganglia (BG) in Ifnb–/– mice while total cells were unaffected (Figures 2M–2O). Among differentially expressed genes in Ifnb–/– neurons, 31 (p = 6.937e-4) were involved in regulating dopamine (DA) signaling (Figure 2P), which is involved in coordinating movements. DA signaling was also defective in the STR. No major differences were found in levels of DA or its metabolite homovanillic acid (HVA) (data not shown) in 3- to 6-month-old Ifnb–/– mice, but the DA metabolite dihydroxyphenylacetic acid (DOPAC) was significantly lower, thus significantly affecting DA/DOPAC and DOPAC/HVA ratios (Figure 2Q). These findings support the importance of IFN-β in regulating dopamine turnover and protecting dopaminergic neurons.
Lack of Neuronal IFN-β-IFNAR Signaling Causes Lewy Bodies
Since Ifnb–/– mice defects overlapped with neurodegenerative diseases, particularly PD, we examined Ifnb–/– brain pathology. Gross anatomy was unchanged, but histological examination showed that Ifnb–/– neuron degeneration was associated with age-dependent α-synucleinopathy. Staining for α-syn was normal in 1.5-month-old Ifnb–/– brains; by 3 months, α-syn was found in LB-like structures in SN; however, α-syn staining intensity was reduced in 12-month-old Ifnb–/– mice (Figures S3A and S3B), likely reflecting degeneration of TH+ neuron (Figure 2L). Alpha-syn and large pathogenic aggregates of phosphorylated (pSer129) α-syn were found in TH+ DA neurons of SN (Figure 3A). At 3 months, α-syn aggregates were widespread in the STR, frontal cortex (Figure 3B), hippocampus, and cerebellum (Figures S3C and S3D). Alpha-syn+ aggregates and neurites were found sporadically in thalamus, the brainstem, and subthalamic regions of 3-month-old Ifnb–/– mice (Figures S3E–S3G). Neurons with α-syn+ LB-like structures increased with age (6- and 12-month-old) in Ifnb–/– mouse thalamus (Figures 3C and 3D). Whole-brain protein extracts from 1.5-month-old mice were not different from WT, but 3-month-old mice had significantly increased α-syn in insoluble fractions and no difference in soluble fractions (Figures 3E–3I). No difference in mRNA for α-syn was observed between Ifnb–/– and WT brains (Figure 3J); thus, the α-syn accumulation was not due to increased transcription. The insoluble α-syn fraction in the BG (including SN) was significantly higher in older mice, but the soluble fraction was still unchanged. A significant increase in high-molecular-weight dimeric, trimeric, and oligomeric α-syn were seen in Ifnb–/– mice, but with a decrease in tetramers. While aggregated α-syn oligomers are neurotoxic (Rockenstein et al., 2014), α-syn tetramers are suggested to be the normal aggregation resistant conformation of the protein (Bartels et al., 2011; Wang et al., 2011), possibly explaining the tetramer abundance in Ifnb+/+ mice. pSer129-α-syn, which is prone to form pathogenic fibrillar aggregates, was increased in Ifnb–/– mice (Figures 3K–3M). Ifnar–/– brains showed a similar pattern to Ifnb–/– regarding α-syn and pSer129-α-syn accumulation (Figure S3H). Blocking with α-syn96–140 peptide confirmed specific immunoreactivity for α-syn in Ifnb–/– brains. To ensure that lack of Ifnb did not generate crossreacting α-syn-independent aggregates, we generated Scna–/–Ifnb–/– double-KO mice (DKO). Ifnb–/– but not Scna–/– or DKO mice had α-syn+ aggregates or LBs (Figures S3I–S3K).
Accumulated polyubiquitinated proteins are associated with neurodegenerative disease (Davies et al., 1997; Hara et al., 2006; Komatsu et al., 2006). While 1.5-month-old WT and Ifnb–/– mice showed not differences, 3-month-old Ifnb–/– brains had increased polyubiquitin (Figures 3N–3R), in hippocampus and cerebellum (Figures S3L and S3M), SN and locus coeruleus (Figures 3O and 3P) and vestibular nuclei of pons (not shown). Ubiquitin accumulated with inclusion body abundance, as seen in the locus coeruleus of 12-month-old Ifnb–/– mice (Figure 3Q) and α-syn+ aggregates colocalizing with ubiquitin and phosphorylated Tau (pTau) significantly increased (Figures 3S and 3T).
To exclude systemic immune response influences, we analyzed Ifnar–/– and nesCre:Ifnarfl/fl mice. Consistent with Ifnb–/– mice, α-syn+ LB-like structures were found in the cerebellum, granular and molecular layers (Figure S3N), and significantly in thalamus of Ifnar–/– and nesCre:Ifnarfl/fl mice (Figure 3U). The ultrastructure of Ifnb–/– and Ifnar–/– neurons in paratenial and central medial thalamic nuclei contained α-syn-immunoreactive perinuclear LB-like structures (Figures 3V and 3W), which were absent in Ifnb+/+ mice (data not shown), underscoring the importance of endogenous IFN-β–IFNAR signaling in preventing neuronal proteinopathy.
Lack of IFN-β Affects Autophagy
We used GSEA to identify cellular pathways involved in Ifnb–/– neuron pathology. In the top 20 deregulated pathways, three were associated with autophagy, which were restored with rIFN-β (Figure 4A; Table S2). The autophagy system uses adaptor proteins SQSTM1/p62 (hereafter p62) and NBR1 to bind ubiquitinated proteins and LC3B-II in the autophagosomal isolation membrane. Upon autophagy, cytosolic LC3B-I is converted to membrane bound LC3B-II and blocking autophagy flux, e.g., with Rab7 defects (Gutierrez et al., 2004; Hyttinen et al., 2013), causes accumulation of autophagy-targeted proteins; p62, NBR1, LC3B-II, and organelles. Increased neurons with accumulated p62 were seen in 3-month-old Ifnb–/– brains compared to WT, predominantly in brainstem, without increased p62 mRNA. LC3B-II increased in BG of 1.5-month-old Ifnb–/–, correlating with increased p62, NBR1 and Rab7, supporting defects in autophagy before α-syn, ubiquitin, pTau, and LB aggregation. Autophagy was even more deregulated in 6- to 8-month Ifnb–/– brains (Figures 4B–4H). Defective autophagy was also confirmed in Ifnar–/– mice (Figure S4).
Senescent or damaged mitochondria are degraded by mitophagy. Large, cytoplasmic, electron-dense aggregates associated with lipid droplets were exclusively found in Ifnb–/– and Ifnar–/– thalamic neurons, which correlated with significantly more mitochondria than in WT (Figures 4I–4M). Cultured Ifnb–/– neurons had significantly lower mitochondrial membrane potential (MMP) than Ifnb+/+ neurons, indicating senescent or damaged mitochondria. MMP was not affected by rIFN-β contrary to positive and negative regulators (Figure 4N). Thus, IFN-β signaling was important in regulating autophagy flux including neuronal mitophagy.
Late-Stage Autophagy Block Causes α-syn Accumulation
Ifnb–/– CNs and CGNs and Ifnar–/– CNs showed autophagy defects resembling a late-stage autophagy block (Figures 5A, 5B, S5A, and S5B). In Ifnb–/– CNs, LC3B-I and LC3B-II were increased with p62, NBR1, and K-63-linked ubiquitin, while K-48-linked ubiquitin only increased slightly (Figures 5A and 5B). Both Ifnb+/+ and Ifnar–/– produced detectable IFN-β, unlike Ifnb–/– neurons (Figure S5C). To validate a block in autophagy flux, fusion between autophagosomes and lysosomes was inhibited with NH4Cl. At 1 hr, LC3B-II levels saturated in both genotypes, which correlated with a significant increase in p62 in Ifnb+/+ CNs; however, Ifnb–/– CNs had nearly saturated p62 levels without treatment, and no significant increase was seen with NH4Cl (Figures 5C and 5D). Autophagy flux was measured in CNs with the mRFP-GFP-LC3B construct, which emits mRFP and GFP signal in autophagosomes and only mRFP in autolysosomes because of low pH in the latter. Ifnb–/– CNs had increased mCherry+GFP+ autophagosomes and very few autolysosomes compared to WT again suggesting blocked autophagy flux. Treating Ifnb+/+ CNs with NH4Cl caused a similar distribution as Ifnb–/– CNs. Rab7 significantly increased in Ifnb–/– CNs, suggesting accumulation of mature autophagosomes. In support, fewer LC3B- and p62-positive autophagic vacuoles overlapped with LAMP1, a lysosomal marker, in Ifnb–/– neurons indicating flux or fusion problems (Figures 5E–5H). GSEA suggested dysregulation in lysosomal genes in Ifnb–/– neurons (Table S2). However, numbers and dysfunction of lysosomes measured as acidification, morphology, or cathepsin expression and activity did not differ in Ifnb+/+ and Ifnb–/– CNs and brains (Figures S5D–S5I).
Ifnb–/– CNs developed ubiquitin+ α-syn aggregates and increased monomeric and high-molecular-weight α-syn after 21 days of culture (Figures 6A and 6B). Accumulation of α-syn was not due to proteasomal defects; turnover of the proteasome substrate p53 after cycloheximide treatment and proteasomal catalytic activity were uncompromised in Ifnb–/– CNs and unchanged by rIFN-β (Figure S6).
Blocking autophagy flux increased LC3B-II and α-syn, and α-syn colocalized with LC3B+ and p62+ autophagosomes in Ifnb–/– CNs (Figures 6C and 6D), underscoring the relevance for autophagic clearance of α-syn. Aggregation-prone pSer129-α-syn was seen in LC3B+ autophagosomes, that rarely overlapped with LAMP1. Collectively, these results demonstrated that lack of IFN-β reduced lysosomal fusion and caused α-syn accumulation.
IFN-β Promotes Neuronal Autophagy and α-syn Clearance
LC3B-II and p62 were higher in untreated Ifnb–/– CNs, and, while overnight rIFN-β-treatment promoted LC3B-II conversion and reduced p62 in Ifnb+/+ CNs, indicating increased autophagy flux, rIFN-β reduced p62 but only slightly increased LC3B-II in Ifnb–/– CNs. By promoting autophagy, rIFN-β reduced α-syn in both Ifnb+/+ and Ifnb–/– CNs (Figures 7A–7D). Effects of rapamycin, an mTOR-dependent autophagy activator, were similar to rIFN-β, but the mTOR-independent inducer trehalose more efficiently reduced α-syn in CNs from both genotypes, possibly through increased α-syn secretion (Ejlerskov et al., 2013). To ensure reconstitution of the genetic defect, we cultured Ifnb–/– neurons with a low rIFN-β dose for 21 days, which increased autophagy flux and α-syn clearance to the level in Ifnb+/+ neurons (Figures 7E and 7F).
Ifnb Gene Therapy Prevents Dopaminergic Neuron Loss in a Familial PD Model
We used lentiviruses to overexpress IFN-β to examine effects on a familial PD model induced with human α-syn (hSCNA) in rat SNs. Injection of hSCNA and control lentiviruses blocked autophagy indicated by accumulated LC3B-II, p62, NBR1, Beclin1, and hSCNA in BG 10 days after SN injection (Decressac et al., 2013) (Figures 7G and 7H). Ifnb overexpression prevented hSCNA and pSer129-α-syn accumulation and restored TH loss. The mice showed improved left paw use compared to right paw use; contralateral to injection side of hSCNA/Ifnb and hSCNA/control viruses, respectively, 21 days post injection, which was associated with preservation of TH+ fibers in SN (Figures 7I and 7J). Ifnb gene therapy also significantly protected TH+ dopaminergic neurons from hSCNA-induced SN damage (Figure 7K). Thus, IFN-β prevented pathology in a familial model of PD by inducing autophagy and α-syn clearance.
Discussion
CNS immune activation and inflammation occur in neurodegenerative diseases (Brochard et al., 2009; Lee et al., 2009; Maccioni et al., 2009; Tansey et al., 2008), but their role in initiation is unclear. We report that defects in IFN-β-IFNAR signaling, that is central to immune regulation, trigger neurodegeneration in the CNS of aging mice. IFN-β promotes neurite growth and protein degradation by autophagy. Lack of IFN-β causes neural pathological changes: accumulation of LB-like structures, neural apoptosis, and neurogenesis defects. p62 accumulated in Ifnb–/– brainstems and BG regions before pathological α-syn aggregation. Aggregates and LB-like structures with α-syn were seen in brainstem and BG including SN, cortex, thalamus, and cerebellum as previously reported in PD and DLB patients (Goedert et al., 2013; Mori et al., 2003).
IFN-β is expressed by neurons to prevent malignant growth (Liu et al., 2013) and neuroinflammation (Liu et al., 2014) and is produced by choroid plexus epithelial cells in aged mouse and human brains without CNS disease (Baruch et al., 2014). In the latter study, injection of an anti-IFNAR antibody in the cerebrospinal fluid, however, positively affected some aspects of cognition. This approach could have complications as injection of full-length antibody might initiate complement-dependent cytotoxicity (Nelson, 2010) and inflammation (Congdon et al., 2013; Linnartz et al., 2012) and cause rapid antibody clearance compared to isotype controls (Sheehan et al., 2006). Genetic generation of Ifnb or Ifnar knockout mice or specifically targeting neuroectodermal cells in nesCre:Ifnarfl/fl mice circumvents such issues. We found that neuronal IFN-β-IFNAR signaling is required for neurons to withstand age-associated pathology. The data also suggest that neuronal IFN-β production in the CNS parenchyma might function differently than high production by choroid plexus epithelial cells or potentially resident microglia.
Familial but not sporadic neurodegenerative diseases are associated with overexpressed or mutant proteins such as α-syn in PD (Thenganatt and Jankovic, 2014). Overexpression of disease-associated proteins (Arima et al., 1999; Jellinger, 2000; Lippa et al., 1998) was not required to accumulate LB-like structures in Ifnb–/–, Ifnar–/–, or nesCre:Ifnarfl/fl neurons. Ifnb or Ifnar deletion was the sole trigger for α-syn-containing inclusion bodies resulting from defective autophagosome maturation. Treatment with rIFN-β promoted autophagy flux and increased α-syn clearance in Ifnb+/+ and Ifnb–/– neurons, supporting IFN-β function in mutated proteins clearance, as suggested with ataxin 7 (Chort et al., 2013). Shared pathology of Ifnb–/– and nesCre:Ifnarfl/fl mice suggests that the pathogenesis is likely driven by initial changes in neuroectodermal neurons rather than systemic or local immune activation. In agreement, neurons are crucial for regulation of CNS inflammation (Liu et al., 2006).
Protein degradation defects are common in neurodegenerative pathologies (Davies et al., 1997; Hara et al., 2006; Komatsu et al., 2006). We found that endogenous neuronal IFN-β signaling is central in regulating protein degradation by autophagy, including clearing aged mitochondria. Accumulated aged and defective mitochondria may release reactive oxygen species, enhancing neuroinflammation and neuronal death (Chaturvedi and Flint Beal, 2013). Cognitive and motoric impairments in PD is associated with DA dysfunction (Narayanan et al., 2013). Excess cytosolic DA is degraded by monoamine oxidase (MAO) in the mitochondrial outer membrane and MAO defects might cause oxidative stress (Segura-Aguilar et al., 2014). Senescent and damaged mitochondria and reduced MAO mRNA were found in Ifnb–/– mice and reduced DOPAC in Ifnb–/– mice supported dysregulation of MAO and mitochondrial genes potentially contributing to neurotoxicity and DA neuron death.
Lack of endogenous IFN-β signaling was associated with spontaneous neurodegeneration, impaired motor coordination and cognition, and neuronal LB-like inclusions with aging as seen in most PD and DLB patients (Jellinger, 2008). Gene profiling supported essential IFN-β regulation of neuronal homeostasis. Neurotrophin was a top hit in GSEA and increased Tox mRNA, important for corticogenesis (Artegiani et al., 2015), supported IFN-β effects on prosurvival mechanisms.
We showed that Ifnb gene therapy reversed pathology in a familial PD model, by promoting autophagy and α-syn clearance, which preserved DA neurons and associated neurologic deficit. Our data strongly support an essential role for IFN-β signaling in preventing neurodegenerative pathology and suggest Ifnb–/– mice as a model for nonfamilial, sporadic neurodegenerative diseases, particularly PD and DLB, with potential for testing future therapies.
Experimental Procedures
For detailed procedures, see Supplemental Experimental Procedures.
Mice and Cell Culture
Ifnb–/– mice (Erlandsson et al., 1998) were backcrossed 20 generations to B10.RIII or C57BL6. Ifnar–/– and nesCre:Ifnarfl/fl mice were in C57BL6 (Prinz et al., 2008). WT were Ifnb+/–, Ifnb+/+ littermates, or Ifnar+/+ C57BL6 mice. C57BL/6JOlaHsd mice (Harlan Laboratories) with a spontaneous deletion of part of Snca (α-syn) were crossed with Ifnb–/– mice for Scna–/–Ifnb–/–. Mice were housed in standard facilities. Sex- and weight-matched mice were used in experiments performed in accordance with the ethical committees in Denmark and approved by our institutional review boards. CGNs were from 6- or 7-day-old cerebella and cortical neuron (CN) cultures from the cortex of 1-day-old mice.
Behavioral Measurements
Motor-coordination and -learning were evaluated with an accelerating RotaRod (TSE Systems GmbH) automatically recording time before fall. Neuromuscular strength was tested by forelimb hanging time on a bar. Heat and cold tail-pain sensitivity was measured by tail-flick latency time after exposure.
Spatial learning and reference memory were assessed with Morris water maze (Vorhees and Williams, 2006) with slight modifications. Swimming patterns were recorded with Ethovision 3.1 (Noldus Information Technology), measuring the time to reach a hidden platform during learning trials and frequency of platform position crossings during probe tests. Deficits prevalence were calculated as behavioral test scores of Ifnb–/– mice that deviated from the norm: mean value (SD/2) of the Ifnb+/+ group (Table S1).
In the cylinder tests, asymmetry in forelimb use during vertical exploration was used as a validated measure of akinesia in hemiparkinsonian rodents.
Cloning
Mouse Ifnb pCR4IFNb was from transOMIC (accession no. BC119395). Ifnb was transferred to pCSII-GW via pCR8TOPOGW (Invitrogen) with conventional cloning techniques to generate pCSII-IFNb. PCSII (without insert) was generated by lambda recombination with an empty pCR8GW vector. Plasmid inserts were verified by sequencing.
Surgery with AAV6-hSCNA
AAV-GFP or AAV-human α-syn/hSNCA-WPRE (Vector Biolabs) together with lentiviral vectors pCSII-IFNb and pCSII control (3 μl for each virus) were injected unilaterally into 30 adult female Sprague Dawley rats (Taconic; 225–250 g at surgery). Virus was infused at 0.2 μl/min as described (Decressac et al., 2013).
Immunohistochemistry, Immunofluorescence, and Transmission Electron Microscopy
For immunohistochemistry (IHC) and immunofluorescence (IF), either mice were perfused and brains fixed in 4% paraformaldehyde (PFA) and paraffin embedded or brains were dissected and snap-frozen before sectioning. In vitro neuronal cultures were fixed in 4% PFA before staining. Tissues and cells were stained as described (Liu et al., 2014).
For neurogenesis and BrdU staining, mice were injected intraperitoneally (i.p.) once per day (75 μg/g body weight) for 5 consecutive days and sacrificed 2 hr after last injection. Brains were processed and immunostained for BrdU and doublecortin (DCX).
MMP was measured by adding tetramethylrhodamine ethyl ester (TMRE) and Hoechst (Life Technologies) to primary CNs.
IF images were taken with a Zeiss LSM510 confocal scanning microscope and IN Cell Analyzer 2200 automated microscope. IHC images were taken with a NanoZoomer 2.0-HT digital slide scanner or Olympus BX51 microscope. Images were quantified with ImageJ (Fiji version), IN Cell Investigator, CellProfiler, Zeiss Zen, and Adobe Photoshop.
In situ apoptosis detection was with TUNEL kits (Calbiochem) with Hoechst counterstaining or DAB substrate and methyl green counterstaining kits (R&D Systems).
For transmission electron microscopy (TEM), 12-month-old mice were cardiac perfused with 2% PFA and 0.2% glutaraldehyde and paratenial, and central medial thalamic nuclei were dissected and processed for epon embedding and ultrathin sectioning. Samples were incubated with primary α-syn antibodies (Leica) and biotinylated (Vector Laboratories) or 1.4-nm gold-labeled secondary antibodies (Nanoprobes) and embedded in epoxy resin. Ultra-thin sections were analyzed in a Philips CM100 electron microscope.
Transfection and Plasmids
CNs were transfected with mRFP-GFP-LC3 using Lipofectamine 2000 (Life Technologies) according to the manufacturer’s description for live-cell confocal imaging.
Stereological Analysis
The optical fractionator method was used to estimate neuron and glial numbers in the hippocampus of 80-μm mouse brain sections stained with H&E. Pointcounting techniques, based on the Cavalieri principle, were used to estimate hippocampal volume on one side of the brain.
Real-Time PCR
Total RNA was isolated using a QIAGEN kit (QIAGEN), reverse transcribed into cDNA, amplified, and quantified by SYBR Green (Bio-Rad) detection. Relative mRNA expression was normalized with glyceraldehyde 3-phosphate dehydrogenase (Gapdh) gene.
High-Performance Liquid Chromatography
Striatum was dissected and homogenized. Filtered supernatant was examined for DA, DOPAC, and HVA levels by reversed-phase HPLCy (Decressac et al., 2013).
Western Blots
Samples were lysed in 1% Triton X-100 (Sigma) and insoluble brain pellets were sonicated in UREA/SDS and processed as described (Ejlerskov et al., 2013).
Affymetrix Microarrays
RNA was extracted with TRI (Sigma) and DNase I (Invitrogen) from 3-day-old Ifnb+/+ and Ifnb–/– CGN cultures in triplicate with or without 24 hr rIFN-β (100 U/ml). Affymetrix 430 2.0 microarray chip (SCIBLU, Affymetrix) data were analyzed with Arraystar 3 (DNA STAR) and quantile-normalized and processed by the RMA (Affymetrix) algorithm. We log2-transformed intensity values, and normal-distributed data were tested in unpaired two-tailed Student’s t tests, filtering for differential regulation confidence of 95% (p < 0.05). Venn diagrams were created with oneChannelGUI (Bioconductor). Quantile-normalized RMA-treated data selected using a 1.4-fold cutoff were analyzed with Ingenuity Pathway Analysis software.
GSEA data heatmaps were generated by extracting lists of core enriched genes from GSEA pathway analysis in R using Heatmap2 (Data S1).
Comparisons of Ifnb–/– CGN gene profiles and published PD and HD models using Affymetrix data (GSE4758, GSE9038) were quantile-normalized together and summarized in R using RMA algorithms from the Affy-package. Differential expression was determined individually within each experiment for our data and published PD and HD models by comparing control/WT samples with transgenic samples using standard ANOVA.
Statistical Analysis
Data were analyzed with unpaired and paired two-tailed Student’s t tests, ANOVA, and Mann-Whitney U, and Kruskal-Wallis tests. p < 0.05 was significant. Error bars are SEM.
Author Contributions
P.E., J.G.H., J.W., R.C., M.K., Y.L., G.P., K.K., M.A., C.F.R., and K.R. did experiments and analyzed and prepared data; B.P. contributed to stereological studies; T.G., D.L., and M.P. did experiments including immunolabeling-EM and Ifnar–/– and nesCre:Ifnarfl/fl mouse analysis; D.C.R. contributed material and designed some protein degradation experiments and S.I.-N. designed and supervised the study, analyzed and interpreted data, and wrote the manuscript. All authors read and contributed to the final manuscript.
Acknowledgments
Support to S.I.-N. was from Danish Council For Independent Research (DFF)-Medical Sciences, Alzheimer-forskningsfonden, Danish Multiple Sclerosis Society, Danish Cancer Society, and Lundbeck Foundation. D.C.R. is a Wellcome Trust Principal Research Fellow. The authors thank Marja Jäättelä for help establishing lysosomal assays, Janne Kock for efficient experimental animal facility arrangement, Elin Pietras for help with IN Cell analysis, Mohamoud Osman, Alexandra Müller, Ana Rita Antunes, Sigrun Nestel, and Barbara Joch for technical assistance, and Klaus Qvortrup for electron microscopy help.
Published: October 8, 2015
Footnotes
Supplemental Information includes Supplemental Experimental Procedures, six figures, two tables, and a data file and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2015.08.069.
Accession Numbers
The accession number for the raw microarray data reported in this paper is Gene Expression Omnibus: GSE63815.
Supplemental Information
References
- Arima K., Hirai S., Sunohara N., Aoto K., Izumiyama Y., Uéda K., Ikeda K., Kawai M. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson’s disease and in dementia with Lewy bodies. Brain Res. 1999;843:53–61. doi: 10.1016/s0006-8993(99)01848-x. [DOI] [PubMed] [Google Scholar]
- Artegiani B., de Jesus Domingues A.M., Bragado Alonso S., Brandl E., Massalini S., Dahl A., Calegari F. Tox: a multifunctional transcription factor and novel regulator of mammalian corticogenesis. EMBO J. 2015;34:896–910. doi: 10.15252/embj.201490061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartels T., Choi J.G., Selkoe D.J. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477:107–110. doi: 10.1038/nature10324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baruch K., Deczkowska A., David E., Castellano J.M., Miller O., Kertser A., Berkutzki T., Barnett-Itzhaki Z., Bezalel D., Wyss-Coray T. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346:89–93. doi: 10.1126/science.1252945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brochard V., Combadière B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J.M. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 2009;119:182–192. doi: 10.1172/JCI36470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chaturvedi R.K., Flint Beal M. Mitochondrial diseases of the brain. Free Radic. Biol. Med. 2013;63:1–29. doi: 10.1016/j.freeradbiomed.2013.03.018. [DOI] [PubMed] [Google Scholar]
- Chort A., Alves S., Marinello M., Dufresnois B., Dornbierer J.G., Tesson C., Latouche M., Baker D.P., Barkats M., El Hachimi K.H. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice. Brain. 2013;136:1732–1745. doi: 10.1093/brain/awt061. [DOI] [PubMed] [Google Scholar]
- Congdon E.E., Gu J., Sait H.B., Sigurdsson E.M. Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance. J. Biol. Chem. 2013;288:35452–35465. doi: 10.1074/jbc.M113.491001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537–548. doi: 10.1016/s0092-8674(00)80513-9. [DOI] [PubMed] [Google Scholar]
- Decressac M., Mattsson B., Weikop P., Lundblad M., Jakobsson J., Björklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc. Natl. Acad. Sci. USA. 2013;110:E1817–E1826. doi: 10.1073/pnas.1305623110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ejlerskov P., Rasmussen I., Nielsen T.T., Bergström A.L., Tohyama Y., Jensen P.H., Vilhardt F. Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion. J. Biol. Chem. 2013;288:17313–17335. doi: 10.1074/jbc.M112.401174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erlandsson L., Blumenthal R., Eloranta M.L., Engel H., Alm G., Weiss S., Leanderson T. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr. Biol. 1998;8:223–226. doi: 10.1016/s0960-9822(98)70086-7. [DOI] [PubMed] [Google Scholar]
- Fossale E., Seong I.S., Coser K.R., Shioda T., Kohane I.S., Wheeler V.C., Gusella J.F., MacDonald M.E., Lee J.M. Differential effects of the Huntington’s disease CAG mutation in striatum and cerebellum are quantitative not qualitative. Hum. Mol. Genet. 2011;20:4258–4267. doi: 10.1093/hmg/ddr355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Francis P.T. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD. J. Neurol. 2009;256(Suppl 3):280–285. doi: 10.1007/s00415-009-5247-7. [DOI] [PubMed] [Google Scholar]
- Goedert M., Spillantini M.G., Del Tredici K., Braak H. 100 years of Lewy pathology. Nat. Rev. Neurol. 2013;9:13–24. doi: 10.1038/nrneurol.2012.242. [DOI] [PubMed] [Google Scholar]
- Gutierrez M.G., Munafó D.B., Berón W., Colombo M.I. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 2004;117:2687–2697. doi: 10.1242/jcs.01114. [DOI] [PubMed] [Google Scholar]
- Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885–889. doi: 10.1038/nature04724. [DOI] [PubMed] [Google Scholar]
- Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2012;8:108–117. doi: 10.1038/nrneurol.2011.200. [DOI] [PubMed] [Google Scholar]
- Hyttinen J.M., Niittykoski M., Salminen A., Kaarniranta K. Maturation of autophagosomes and endosomes: a key role for Rab7. Biochim. Biophys. Acta. 2013;1833:503–510. doi: 10.1016/j.bbamcr.2012.11.018. [DOI] [PubMed] [Google Scholar]
- Jellinger K.A. Morphological substrates of mental dysfunction in Lewy body disease: an update. J. Neural Transm. Suppl. 2000;59:185–212. doi: 10.1007/978-3-7091-6781-6_21. [DOI] [PubMed] [Google Scholar]
- Jellinger K.A. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener. Dis. 2008;5:118–121. doi: 10.1159/000113679. [DOI] [PubMed] [Google Scholar]
- Jellinger K.A., Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. 2008;115:427–436. doi: 10.1007/s00401-008-0347-5. [DOI] [PubMed] [Google Scholar]
- Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880–884. doi: 10.1038/nature04723. [DOI] [PubMed] [Google Scholar]
- Lee Y.K., Kwak D.H., Oh K.W., Nam S.Y., Lee B.J., Yun Y.W., Kim Y.B., Han S.B., Hong J.T. CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. Neurobiol. Learn. Mem. 2009;92:356–363. doi: 10.1016/j.nlm.2009.04.003. [DOI] [PubMed] [Google Scholar]
- Linnartz B., Kopatz J., Tenner A.J., Neumann H. Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia. J. Neurosci. 2012;32:946–952. doi: 10.1523/JNEUROSCI.3830-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O’Connell B., Pollen D.A., St George-Hyslop P. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 1998;153:1365–1370. doi: 10.1016/s0002-9440(10)65722-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Y., Teige I., Birnir B., Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 2006;12:518–525. doi: 10.1038/nm1402. [DOI] [PubMed] [Google Scholar]
- Liu Y., Carlsson R., Ambjørn M., Hasan M., Badn W., Darabi A., Siesjö P., Issazadeh-Navikas S. PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients. J. Neurosci. 2013;33:14231–14245. doi: 10.1523/JNEUROSCI.5812-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Y., Carlsson R., Comabella M., Wang J., Kosicki M., Carrion B., Hasan M., Wu X., Montalban X., Dziegiel M.H. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nat. Med. 2014;20:272–282. doi: 10.1038/nm.3485. [DOI] [PubMed] [Google Scholar]
- Maccioni R.B., Rojo L.E., Fernández J.A., Kuljis R.O. The role of neuroimmunomodulation in Alzheimer’s disease. Ann. N Y Acad. Sci. 2009;1153:240–246. doi: 10.1111/j.1749-6632.2008.03972.x. [DOI] [PubMed] [Google Scholar]
- Mori F., Piao Y.S., Hayashi S., Fujiwara H., Hasegawa M., Yoshimoto M., Iwatsubo T., Takahashi H., Wakabayashi K. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J. Neuropathol. Exp. Neurol. 2003;62:812–819. doi: 10.1093/jnen/62.8.812. [DOI] [PubMed] [Google Scholar]
- Mrak R.E., Griffin W.S. Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease. Neuropsychiatr. Dis. Treat. 2007;3:619–625. [PMC free article] [PubMed] [Google Scholar]
- Narayanan N.S., Rodnitzky R.L., Uc E.Y. Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. Rev. Neurosci. 2013;24:267–278. doi: 10.1515/revneuro-2013-0004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson A.L. Antibody fragments: hope and hype. MAbs. 2010;2:77–83. doi: 10.4161/mabs.2.1.10786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prinz M., Schmidt H., Mildner A., Knobeloch K.P., Hanisch U.K., Raasch J., Merkler D., Detje C., Gutcher I., Mages J. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 2008;28:675–686. doi: 10.1016/j.immuni.2008.03.011. [DOI] [PubMed] [Google Scholar]
- Rockenstein E., Nuber S., Overk C.R., Ubhi K., Mante M., Patrick C., Adame A., Trejo-Morales M., Gerez J., Picotti P. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain. 2014;137:1496–1513. doi: 10.1093/brain/awu057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Segura-Aguilar J., Paris I., Muñoz P., Ferrari E., Zecca L., Zucca F.A. Protective and toxic roles of dopamine in Parkinson’s disease. J. Neurochem. 2014;129:898–915. doi: 10.1111/jnc.12686. [DOI] [PubMed] [Google Scholar]
- Sheehan K.C., Lai K.S., Dunn G.P., Bruce A.T., Diamond M.S., Heutel J.D., Dungo-Arthur C., Carrero J.A., White J.M., Hertzog P.J., Schreiber R.D. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 2006;26:804–819. doi: 10.1089/jir.2006.26.804. [DOI] [PubMed] [Google Scholar]
- Shulman J.M., De Jager P.L. Evidence for a common pathway linking neurodegenerative diseases. Nat. Genet. 2009;41:1261–1262. doi: 10.1038/ng1209-1261. [DOI] [PubMed] [Google Scholar]
- Tansey M.G., Frank-Cannon T.C., McCoy M.K., Lee J.K., Martinez T.N., McAlpine F.E., Ruhn K.A., Tran T.A. Neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy? Front. Biosci. 2008;13:709–717. doi: 10.2741/2713. [DOI] [PubMed] [Google Scholar]
- Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 2003;170:4776–4784. doi: 10.4049/jimmunol.170.9.4776. [DOI] [PubMed] [Google Scholar]
- Teige I., Liu Y., Issazadeh-Navikas S. IFN-beta inhibits T cell activation capacity of central nervous system APCs. J. Immunol. 2006;177:3542–3553. doi: 10.4049/jimmunol.177.6.3542. [DOI] [PubMed] [Google Scholar]
- Thenganatt M.A., Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014;71:499–504. doi: 10.1001/jamaneurol.2013.6233. [DOI] [PubMed] [Google Scholar]
- Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006;1:848–858. doi: 10.1038/nprot.2006.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang W., Perovic I., Chittuluru J., Kaganovich A., Nguyen L.T., Liao J., Auclair J.R., Johnson D., Landeru A., Simorellis A.K. A soluble α-synuclein construct forms a dynamic tetramer. Proc. Natl. Acad. Sci. USA. 2011;108:17797–17802. doi: 10.1073/pnas.1113260108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yong V.W., Chabot S., Stuve O., Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology. 1998;51:682–689. doi: 10.1212/wnl.51.3.682. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.